hotspot -WSS

hotspot

author：Wikipedia 2025-08-06 04:47:41 - browse：5641

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

WSS

Extensive review finds private equity owners jack up cost of care

NIH launches clinical trials and new research office for long Covid

Micronoma's microbiome cancer diagnostic approach under fire

Vertex non

Micronoma's microbiome cancer diagnostic approach under fire

Caribou posts encouraging results on off

knowledge

hotspot

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The stock market has soared this year, but will it last? Experts weigh in

23andMe had bad news about my health. I wish a person had delivered it

'CMA Fest' 2023: How to watch, who is performing and more

Activists slam private health insurers over coverage restrictions

Trump indictment: Who are the 'co

After affirmative action ruling, medical educators look to 'holistic review'

National panel will explore requiring free Covid tests

What does generative AI mean for health care? We asked experts

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

leisure time

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

NIH launches clinical trials and new research office for long Covid

What the airline industry can learn from medicine

How a Boston hospital is priming medical residents to use GPT

What the airline industry can learn from medicine

Adults seen as increasingly susceptible to measles

hotspot

Wikipedia

Wikipedia

knowledge